Cas:53-45-2 (8R,9S,13S,14S)-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one manufacturer & supplier

Chemical Name:(8R,9S,13S,14S)-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one

CAS.NO:53-45-2

Synonyms:Agrestin;Desoxyestrone;estra-1,3,5(10)-trien-17-one;1,3,5(10)-estratrien-17-one;d-Estra-1,3,5(10)-trien-17-one;Deoxyestrone;3-Deoxyestrone;1,3,5(10)-Estratrien-17-one;3-Deoxyoestrone;Estratrien-17-one;Estrone,3-deoxy;3-Desoxyestrone;Adopron;Oestra-1,3,5(10)-trien-17-one

Molecular Formula:C₁₈H₂₂O

Molecular Weight:254.36700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:387ºC at 760mmHg

Density:1.088g/cm3

Index of Refraction:1.565

PSA:17.07000

Exact Mass:254.16700

LogP:4.11180

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Agrestin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Oestra-1,3,5(10)-trien-17-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Deoxyestrone Use and application,1,3,5(10)-estratrien-17-one technical grade,usp/ep/jp grade.

Related News: The agency’s first recommendation was straightforward: “Stop using the Innova SARS-CoV-2 Antigen Rapid Qualitative Test. Destroy the tests by placing them in the trash or return the tests to Innova using the FedEx return label that was included with the recall letter that Innova sent to customers.” (8R,9S,13S,14S)-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one manufacturer Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. (8R,9S,13S,14S)-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one supplier The agency’s first recommendation was straightforward: “Stop using the Innova SARS-CoV-2 Antigen Rapid Qualitative Test. Destroy the tests by placing them in the trash or return the tests to Innova using the FedEx return label that was included with the recall letter that Innova sent to customers.” (8R,9S,13S,14S)-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one vendor Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. (8R,9S,13S,14S)-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one factory In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.